Stock Scorecard
Stock Summary for Tenax Therapeutics Inc (TENX) - $11.91 as of 5/14/2026 12:28:18 PM EST
Total Score
8 out of 30
Safety Score
32 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for TENX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for TENX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for TENX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for TENX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for TENX (32 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for TENX
Financial Details for TENX
Company Overview |
|
|---|---|
| Ticker | TENX |
| Company Name | Tenax Therapeutics Inc |
| Country | USA |
| Description | Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing, and marketing products for cardiovascular and pulmonary disease in the United States and Canada. The company is headquartered in Morrisville, North Carolina. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | 5/13/2026 |
Stock Price History |
|
| Last Day Price | 11.91 |
| Price 4 Years Ago | 178.24 |
| Last Day Price Updated | 5/14/2026 12:28:18 PM EST |
| Last Day Volume | 432,733 |
| Average Daily Volume | 643,988 |
| 52-Week High | 18.38 |
| 52-Week Low | 5.34 |
| Last Price to 52 Week Low | 123.03% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 33.01 |
| Sector PE | 91.46 |
| 5-Year Average PE | -16.73 |
| Free Cash Flow Ratio | 3.14 |
| Industry Free Cash Flow Ratio | 21.03 |
| Sector Free Cash Flow Ratio | 33.52 |
| Current Ratio Most Recent Quarter | 14.56 |
| Total Cash Per Share | 3.79 |
| Book Value Per Share Most Recent Quarter | 2.29 |
| Price to Book Ratio | 3.09 |
| Industry Price to Book Ratio | 6.43 |
| Sector Price to Book Ratio | 24.00 |
| Price to Sales Ratio Twelve Trailing Months | 414.72 |
| Industry Price to Sales Ratio Twelve Trailing Months | 7.05 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.35 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 25,775,500 |
| Market Capitalization | 306,986,205 |
| Institutional Ownership | 45.58% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.39% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -198.82% |
| Reported EPS 12 Trailing Months | -1.34 |
| Reported EPS Past Year | -0.35 |
| Reported EPS Prior Year | -1.33 |
| Net Income Twelve Trailing Months | -52,599,000 |
| Net Income Past Year | -52,599,000 |
| Net Income Prior Year | -17,602,000 |
| Quarterly Revenue Growth YOY | 0.00% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | 0.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 97,565,000 |
| Total Cash Past Year | 97,565,000 |
| Total Cash Prior Year | 94,851,000 |
| Net Cash Position Most Recent Quarter | 97,286,198 |
| Net Cash Position Past Year | 97,064,097 |
| Long Term Debt Past Year | 500,903 |
| Long Term Debt Prior Year | 624,302 |
| Total Debt Most Recent Quarter | 278,802 |
| Equity to Debt Ratio Past Year | 0.99 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 97,071,000 |
| Total Stockholder Equity Prior Year | 91,993,000 |
| Total Stockholder Equity Most Recent Quarter | 97,071,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -35,800,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.39 |
| Free Cash Flow Past Year | -35,800,000 |
| Free Cash Flow Prior Year | -14,811,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.57 |
| MACD Signal | -0.30 |
| 20-Day Bollinger Lower Band | 10.32 |
| 20-Day Bollinger Middle Band | 13.28 |
| 20-Day Bollinger Upper Band | 16.24 |
| Beta | 1.00 |
| RSI | 35.48 |
| 50-Day SMA | 9.59 |
| 150-Day SMA | 10.13 |
| 200-Day SMA | 53.26 |
System |
|
| Modified | 5/14/2026 7:20:51 AM EST |